Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRNX |
---|---|---|
09:32 ET | 5243 | 50.32 |
09:34 ET | 300 | 50.95 |
09:36 ET | 770 | 50.93 |
09:38 ET | 1238 | 51.01 |
09:39 ET | 600 | 51.18 |
09:41 ET | 2589 | 51.01 |
09:43 ET | 8290 | 50.65 |
09:45 ET | 1413 | 50.55 |
09:48 ET | 1691 | 50.525 |
09:50 ET | 10001 | 50.535 |
09:52 ET | 1400 | 50.39 |
09:54 ET | 3188 | 50.38 |
09:56 ET | 1300 | 50.38 |
09:57 ET | 40428 | 50.38 |
09:59 ET | 6735 | 50.385 |
10:01 ET | 2648 | 50.19 |
10:03 ET | 4697 | 50.205 |
10:06 ET | 24421 | 50.12 |
10:08 ET | 959 | 50.2 |
10:10 ET | 106068 | 50.2 |
10:12 ET | 2895 | 50.2 |
10:14 ET | 1555 | 50.2 |
10:15 ET | 3911 | 50.25 |
10:17 ET | 4607 | 50.185 |
10:19 ET | 200 | 50.25 |
10:21 ET | 485 | 50.1415 |
10:24 ET | 8064 | 50.17 |
10:26 ET | 8653 | 50.275 |
10:28 ET | 900 | 50.13 |
10:30 ET | 497 | 50.1 |
10:32 ET | 16193 | 50.12 |
10:33 ET | 400 | 50.16 |
10:35 ET | 842 | 50.2 |
10:37 ET | 4072 | 50.145 |
10:39 ET | 200 | 50.15 |
10:42 ET | 3912 | 50.2 |
10:44 ET | 600 | 50.2025 |
10:46 ET | 6558 | 50.425 |
10:48 ET | 2074 | 50.445 |
10:50 ET | 2241 | 50.44 |
10:51 ET | 900 | 50.42 |
10:53 ET | 600 | 50.41 |
10:55 ET | 1600 | 50.4 |
10:57 ET | 516 | 50.42 |
11:00 ET | 2253 | 50.42 |
11:02 ET | 5176 | 50.5 |
11:04 ET | 1698 | 50.44 |
11:06 ET | 500 | 50.5 |
11:08 ET | 100 | 50.5 |
11:09 ET | 600 | 50.51 |
11:11 ET | 405 | 50.5 |
11:13 ET | 100 | 50.5 |
11:15 ET | 1902 | 50.535 |
11:18 ET | 3234 | 50.65 |
11:20 ET | 2100 | 50.65 |
11:22 ET | 1095 | 50.665 |
11:24 ET | 23242 | 50.57 |
11:26 ET | 3003 | 50.62 |
11:27 ET | 100 | 50.57 |
11:29 ET | 2903 | 50.56 |
11:31 ET | 200 | 50.61 |
11:33 ET | 1980 | 50.605 |
11:36 ET | 253 | 50.595 |
11:38 ET | 3814 | 50.855 |
11:40 ET | 508 | 50.72 |
11:44 ET | 750 | 50.8 |
11:45 ET | 200 | 50.72 |
11:47 ET | 1423 | 50.615 |
11:49 ET | 600 | 50.5 |
11:51 ET | 200 | 50.53 |
11:54 ET | 400 | 50.5 |
11:56 ET | 33823 | 50.525 |
11:58 ET | 753 | 50.46 |
12:00 ET | 400 | 50.44 |
12:02 ET | 300 | 50.35 |
12:03 ET | 667 | 50.5 |
12:07 ET | 800 | 50.505 |
12:09 ET | 431 | 50.485 |
12:12 ET | 2328 | 50.485 |
12:14 ET | 1054 | 50.46 |
12:16 ET | 954 | 50.49 |
12:18 ET | 100 | 50.42 |
12:20 ET | 100 | 50.41 |
12:21 ET | 1325 | 50.41 |
12:23 ET | 100 | 50.4 |
12:25 ET | 585 | 50.415 |
12:30 ET | 200 | 50.3804 |
12:32 ET | 250 | 50.41 |
12:34 ET | 1200 | 50.4374 |
12:36 ET | 100 | 50.45 |
12:39 ET | 500 | 50.5 |
12:41 ET | 600 | 50.52 |
12:43 ET | 122 | 50.45 |
12:45 ET | 1000 | 50.5 |
12:48 ET | 200 | 50.5 |
12:50 ET | 3300 | 50.72 |
12:52 ET | 810 | 50.78 |
12:54 ET | 369 | 50.75 |
12:56 ET | 100 | 50.765 |
12:57 ET | 200 | 50.77 |
12:59 ET | 400 | 50.67 |
01:01 ET | 443 | 50.715 |
01:03 ET | 350 | 50.7 |
01:06 ET | 600 | 50.6875 |
01:10 ET | 200 | 50.73 |
01:12 ET | 100 | 50.705 |
01:14 ET | 200 | 50.66 |
01:15 ET | 1869 | 50.66 |
01:17 ET | 200 | 50.66 |
01:19 ET | 1341 | 50.715 |
01:21 ET | 100 | 50.65 |
01:26 ET | 100 | 50.64 |
01:28 ET | 100 | 50.68 |
01:30 ET | 925 | 50.535 |
01:32 ET | 300 | 50.52 |
01:33 ET | 700 | 50.595 |
01:35 ET | 623 | 50.64 |
01:37 ET | 100 | 50.575 |
01:39 ET | 300 | 50.65 |
01:42 ET | 100 | 50.72 |
01:44 ET | 100 | 50.69 |
01:46 ET | 200 | 50.7 |
01:48 ET | 628 | 50.6675 |
01:50 ET | 600 | 50.68 |
01:51 ET | 100 | 50.72 |
01:53 ET | 100 | 50.69 |
01:55 ET | 300 | 50.69 |
01:57 ET | 303 | 50.65 |
02:00 ET | 400 | 50.68 |
02:04 ET | 700 | 50.74 |
02:06 ET | 300 | 50.79 |
02:08 ET | 200 | 50.83 |
02:09 ET | 100 | 50.88 |
02:11 ET | 100 | 50.885 |
02:15 ET | 331 | 50.9 |
02:18 ET | 965 | 50.79 |
02:20 ET | 200 | 50.765 |
02:22 ET | 200 | 50.74 |
02:24 ET | 700 | 50.73 |
02:26 ET | 100 | 50.705 |
02:27 ET | 566 | 50.69 |
02:29 ET | 600 | 50.72 |
02:31 ET | 900 | 50.66 |
02:33 ET | 400 | 50.665 |
02:36 ET | 700 | 50.64 |
02:38 ET | 884 | 50.61 |
02:40 ET | 100 | 50.58 |
02:42 ET | 600 | 50.46 |
02:44 ET | 300 | 50.45 |
02:45 ET | 300 | 50.42 |
02:47 ET | 400 | 50.38 |
02:49 ET | 700 | 50.37 |
02:51 ET | 1937 | 50.51 |
02:54 ET | 1400 | 50.57 |
02:56 ET | 2476 | 50.57 |
02:58 ET | 300 | 50.53 |
03:00 ET | 698 | 50.48 |
03:02 ET | 300 | 50.49 |
03:03 ET | 1900 | 50.53 |
03:05 ET | 2082 | 50.51 |
03:07 ET | 412 | 50.565 |
03:09 ET | 745 | 50.545 |
03:12 ET | 393 | 50.47 |
03:14 ET | 833 | 50.425 |
03:16 ET | 300 | 50.41 |
03:18 ET | 72300 | 50.55 |
03:20 ET | 2754 | 50.54 |
03:21 ET | 300 | 50.52 |
03:23 ET | 1567 | 50.39 |
03:25 ET | 200 | 50.2 |
03:27 ET | 2300 | 50.18 |
03:30 ET | 1316 | 50.205 |
03:32 ET | 1008 | 50.19 |
03:34 ET | 2659 | 50.22 |
03:36 ET | 65741 | 50.275 |
03:38 ET | 2100 | 50.225 |
03:39 ET | 2330 | 50.28 |
03:41 ET | 1000 | 50.31 |
03:43 ET | 2845 | 50.28 |
03:45 ET | 9169 | 50.31 |
03:48 ET | 2675 | 50.4 |
03:50 ET | 10090 | 50.45 |
03:52 ET | 10637 | 50.43 |
03:54 ET | 7816 | 50.45 |
03:56 ET | 18865 | 50.43 |
03:57 ET | 13610 | 50.445 |
03:59 ET | 128869 | 50.49 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.9B | -13.4x | --- |
Nuvalent Inc | 4.4B | -29.7x | --- |
Immunovant Inc | 4.4B | -16.9x | --- |
Summit Therapeutics Inc | 3.3B | -2.9x | --- |
Biohaven Ltd | 3.3B | -5.4x | --- |
Madrigal Pharmaceuticals Inc | 4.5B | -9.2x | --- |
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.9B |
---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.67 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -13.4x |
Price/Sales (TTM) | 1,969.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.